Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Looking for reliable websites to aid your investment learning? Check out our curated list of resources that support new investors on their journey.
28,161 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
A fresh web app enables 24/7 ownership of tokenized rare metals, including gold and uranium, with vault-backed receip...
A wave of new rail regulations is moving through Washington, with the White House and Congress aiming to curb abuses....
Strategy unveiled a broad capital-management package to steady its Bitcoin-buying strategy, but analysts say the next...
Three fast-growing tech names are drawing July attention, each amid clear AI-driven catalysts and strong quarterly ga...
Strategy (formerly MicroStrategy) appears poised to complete its 100th Bitcoin purchase, signaling a bold continuatio...
Anthropic’s latest coding assistant is reshaping how enterprises buy software, potentially ending seat-based licenses...
JPMorgan raised its price target on Dell Technologies to 280 amid easing memory headwinds and a robust AI server back...
Commvault sits in the shadows of bigger cybersecurity names, but its improving ARR and reasonable valuation may offer...
Coinbase stock faces a tough year, but cost reductions and a rebound in crypto activity could spark a meaningful rall...
Investors face a stark choice in 2026: back an infrastructure-focused sand and logistics player in the Permian or bac...
When sentiment hits extreme fear, smart investors pause and plan. This guide explains what the crypto market flashing...